'Miracle': A drug trial erases cancer from every patient's body
1/6
First time in history
For the 'first time in history', a group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months.
2/6
Drug called 'Dostarlimab'
18 patients took a drug called Dostarlimab for around six months in a small clinical trial conducted by the Memorial Sloan Kettering Cancer Center. In the end, every one of them saw their tumours disappear, New York Times reported.
3/6
'Potential' cure
Dostarlimab is a drug with laboratory-produced molecules and it acts as substitute antibodies in the human body. The patients underwent a series of medical exams -- physical, endoscopy, bioscopy, PET scans and MRI scans -- and none of the reports showed a tumour.
Amazon Top Deals
POWERED BY
Crompton Ozone 75 Litres Desert Air Cooler for home | Large & Easy Clean Ice Chamber | 4-Way Air Deflection | High Density Honeycomb Pads | Everlast Pump | Auto Fill| 3 Year Brand Warranty
₹9,798Buy Now43%
OFF
atomberg Studio Smart+ 1200mm BLDC Ceiling Fan with IoT & Remote | BEE 5 star Rated Energy Efficient Ceiling Fan | High Air Delivery with LED Indicators | 3 Year Warranty (Earth Brown)
₹5,882Buy Now36%
OFF
LG 32 L Convection Microwave Oven (MC3286BRUM, Black, 360° Motorised Rotisserie for Bar-be-queing, 301 Auto Cook Menu, Stainless steel cavity, Indian Cuisine, Tandoor Se, Steam Clean & Diet Fry)
₹19,340Buy Now19%
OFF
4/6
More about the clinical trial
Patients involved in the clinical trial earlier underwent treatments such as chemotherapy, radiation, and invasive surgery that could result in bowel, urinary, and even sexual dysfunction. They then went into the trial expecting to have to go through these procedures as the next step. However, to their surprise, no further treatment was needed.
5/6
What reports say
The findings of this trial have shocked experts and they have pointed out that complete remission in every single patient is "unheard-of". Dr Alan P. Venook, who is a colorectal cancer specialist at the University of California, hailed the research as "world-first". Not all of the patients suffered significant complications from the drug trial.
6/6
Indian-origin patient
An Indian origin patient was among those who had the "miracle" cure. "It's a miracle", Nisha Varughese said about the immunotherapy drug's efficacy in curing her.